Toxocariasis: Una Enfermedad Tropical Desatendida y Descuidada en Latinoamérica

Autores/as

  • Alfonso J. Rodriguez-Morales Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru; Program of Family Medicine Specialization, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas-Institución Universitaria Visión de las Américas, Pereira, Colombia. https://orcid.org/0000-0001-9773-2192
  • Ivan Camilo Jaramillo-Montoya Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0008-8550-705X
  • Jessica Marcela Hermosa-Sanchez Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0000-0003-4733-9434
  • Juan Felipe López-Marín Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0002-4931-7183
  • Maria Camila Bernal-Chica Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0001-6595-0811
  • Nahun Alejandro Giraldo-Corrales Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0004-2671-7509
  • Omar Jair Mantilla-Moreno Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0007-9636-4528
  • Hector Andres Mosquera-Alba Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0003-5287-2468
  • Sergio Imbachi-Anacona Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0002-0852-8937
  • Luis Daniel Reyes-Espinosa Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0009-0008-7638-3024
  • Juan Pablo Hernández-Ovalle Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru. https://orcid.org/0000-0001-5236-0815
  • Olinda Delgado Immunoparasitology Section, Tropical Medicine Institute, Universidad Central de Venezuela, Caracas, Venezuela. https://orcid.org/0009-0000-5037-2898

DOI:

https://doi.org/10.35434/rcmhnaaa.2025.181.2835

Palabras clave:

Toxocariasis, Enfermedades Tropicales Desatendidas, Zoonosis, América Latina, Larva Migrans, Una Salud, Infecciones Parasitarias

Resumen

La toxocariasis es una infección parasitaria zoonótica causada principalmente por Toxocara canis y T. cati. Esta condición sigue siendo un problema de salud pública desatendido, pero ampliamente distribuido en América Latina. Esta revisión explora sus dimensiones biológicas, clínicas, epidemiológicas y socioeconómicas, haciendo énfasis en el escaso reconocimiento de la enfermedad, incluso en áreas endémicas. La transmisión ocurre mediante la ingestión accidental de huevos embrionados presentes en ambientes contaminados, afectando particularmente a niños en contextos de bajos ingresos. En los seres humanos, las larvas migran de manera aberrante, causando síndromes viscerales, oculares y neurológicos con una morbilidad significativa. La carga de la enfermedad se ve agravada por la infraestructura diagnóstica limitada, el acceso inconsistente a terapias antiparasitarias, los controles veterinarios y ambientales inadecuados. Se han reportado altas tasas de seroprevalencia y contaminación ambiental en toda América Latina. Sin embargo, la toxocariasis no figura actualmente en la lista de enfermedades tropicales desatendidas (ETD) de la Organización Mundial de la Salud (OMS). Las asociaciones con asma, epilepsia y otras condiciones crónicas refuerzan aún más su relevancia en salud pública. Los desafíos diagnósticos derivan de la ausencia de huevos en las heces humanas y de la necesidad de herramientas serológicas y de imágenes especializadas. Las innovaciones emergentes en diagnósticos rápidos y el desarrollo de vacunas, particularmente dentro del enfoque de Una Salud (One Health), ofrecen esperanzas para un mejor control. No obstante, las barreras sistémicas, incluidas las inequidades socioeconómicas, la falta de conciencia y la escasa priorización política, siguen obstaculizando el progreso hacia su control. Esta revisión aboga por el reconocimiento formal de la toxocariasis como una ETD, lo que catalizaría la financiación, la investigación y las medidas de control coordinadas. Abordar la toxocariasis en América Latina requiere estrategias integradas y multisectoriales que prioricen a las poblaciones más vulnerables, en consonancia con los objetivos más amplios de equidad en salud y prevención de enfermedades zoonóticas.

 

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Alfonso J. Rodriguez-Morales, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru; Program of Family Medicine Specialization, Faculty of Medicine, Fundación Universitaria Autónoma de las Américas-Institución Universitaria Visión de las Américas, Pereira, Colombia.

    1. Médico

    2. Magister

  • Ivan Camilo Jaramillo-Montoya, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Jessica Marcela Hermosa-Sanchez, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Juan Felipe López-Marín, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Maria Camila Bernal-Chica, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Nahun Alejandro Giraldo-Corrales, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Omar Jair Mantilla-Moreno, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Hector Andres Mosquera-Alba, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Sergio Imbachi-Anacona, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Luis Daniel Reyes-Espinosa, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Juan Pablo Hernández-Ovalle, Master of Clinical Epidemiology and Biostatistics Program, Faculty of Health Sciences, Universidad Científica del Sur, Lima, Peru.

    1. Médico

  • Olinda Delgado, Immunoparasitology Section, Tropical Medicine Institute, Universidad Central de Venezuela, Caracas, Venezuela.

    1. Doctor

Referencias

Delgado O, Rodríguez-Morales AJ. Aspectos clínico-epidemiológicos de la toxocariasis: una enfermedad desatendida en Venezuela y América Latina. Boletín de Malariología y Salud Ambiental [Internet]. 2009 [Citado el 22 de enero del 2024];49(1):1-17. Disponible en: https://goo.su/qpYfBu

Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003;16(2):265-72. Doi: 10.1128/cmr.16.2.265-272.2003.

Bonilla-Aldana DK, Morales-Garcia LV, Ulloque Badaracco JR, Mosquera-Rojas MD, Alarcón-Braga EA, Hernandez-Bustamante EA, et al. Prevalence of Toxocara eggs in Latin American parks: a systematic review and meta-analysis. Infez Med. 2023;31(3):329-49. Doi: 10.53854/liim-3103-7.

Carlin EP, Tyungu DL. Toxocara: Protecting pets and improving the lives of people. Adv Parasitol. 2020;109:3-16. Doi: 10.1016/bs.apar.2020.01.001.

Woodhall DM, Garcia AP, Shapiro CA, Wray SL, Shane AL, Mani CS, et al. Assessment of U.S. Pediatrician Knowledge of Toxocariasis. Am J Trop Med Hyg. 2017;97(4):1243-6. Doi: 10.4269/ajtmh.17-0232.

Phasuk N, Punsawad C. Seroprevalence of Toxocara canis infection and associated risk factors among primary schoolchildren in rural Southern Thailand. Trop Med Health. 2020;48:23. Doi: 10.1186/s41182-020-00211-0.

Foroutan M, Vafae Eslahi A, Soltani S, Kamyari N, Moradi-Joo E, Magnaval JF, et al. Seroprevalence and Potential Risk Factors of Toxocariasis among General Population in Southwest Iran: Implications on the One Health Approach. J Immunol Res. 2024;2024:4246781. Doi: 10.1155/2024/4246781.

Pourshahbazi G, Khanahmad H, Khadivi R, Yousefi HA, Mobarakeh S, Boldaji FH, et al. Toxocara Infection in Dogs and Cats in Isfahan Province of Iran in 2021. Adv Biomed Res. 2023;12:201. Doi: 10.4103/abr.abr_88_22.

Merigueti Y, Santarém VA, Ramires LM, da Silveira Batista A, da Costa Beserra LV, Nuci AL, et al. Protective and risk factors associated with the presence of Toxocara spp. eggs in dog hair. Vet Parasitol. 2017;244:39-43. Doi: 10.1016/j.vetpar.2017.07.020.

Köchle BR, Garijo-Toledo MM, Llobat L, Sansano-Maestre J. Prevalence of Toxocara Eggs in Public Parks in the City of Valencia (Eastern Spain). Vet Sci. 2022;9(5). Doi: 10.3390/vetsci9050232.

Chidumayo NN. Prevalence of Toxocara in dogs and cats in Africa. Adv Parasitol. 2020;109:861-71. Doi: 10.1016/bs.apar.2020.01.032.

Fan CK, Holland CV, Loxton K, Barghouth U. Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders? Clin Microbiol Rev. 2015;28(3):663-86. Doi: 10.1128/cmr.00106-14.

Hombu A, Yoshida A, Kikuchi T, Nagayasu E, Kuroki M, Maruyama H. Treatment of larva migrans syndrome with long-term administration of albendazole. J Microbiol Immunol Infect. 2019;52(1):100-5. Doi: 10.1016/j.jmii.2017.07.002.

Bolivar-Mejia A, Alarcón-Olave C, Calvo-Betancourt LS, Paniz-Mondolfi A, Delgado O, Rodriguez-Morales AJ. Toxocariasis in the Americas: Burden and Disease Control. Current Tropical Medicine Reports. 2014;1(1):62-8. Doi: 10.1007/s40475-013-0010-7.

Rodriguez-Morales AJ, Bonilla-Aldana DK, Gallego-Valencia V, Gómez-DeLaRosa SH, López-Echeverri C, Peña-Verjan NM, et al. Toxocariasis in Colombia: More Than Neglected. Current Tropical Medicine Reports. 2020;7(1):17-24. Doi: 10.1007/s40475-020-00199-x.

Minamii T, Nishioka H. Case Report: Toxocariasis Manifesting as Eosinophilic Pleural Effusion. Am J Trop Med Hyg. 2024;110(4):687-90. Doi: 10.4269/ajtmh.23-0343.

Ciarmela ML, Pezzani BC, Minvielle MC. Toxocariasis, Intestinal Parasitoses and Eosinophilia in Schoolchildren from Argentina. Curr Health Sci J. 2016;42(1):5-11. Doi: 10.12865/chsj.42.01.01.

Sayas I, Álvarez P, Pajuelo R, Luque W, Tassara C. [Atypical presentation of infant toxocariasis: About a case]. Rev Chilena Infectol. 2021;38(5):698-701. Doi: 10.4067/s0716-10182021000500698.

Brindley PJ, Hotez PJ, Kamhawi S. Revisiting What Constitutes a Neglected Tropical Disease? PLoS Negl Trop Dis. 2025;19(2):e0012794. Doi: 10.1371/journal.pntd.0012794.

Antonopoulos A, Giannelli A, Morgan ER, Charlier J. Quantifying the neglected: Initial estimation of the global burden and economic impact of human toxocariasis. Curr Res Parasitol Vector Borne Dis. 2024;5:100180. Doi: 10.1016/j.crpvbd.2024.100180.

Xie Y, Wang L, Chen Y, Wang Z, Zhu P, Hu Z, et al. The Complete Mitogenome of Toxocara vitulorum: Novel In-Sights into the Phylogenetics in Toxocaridae. Animals (Basel). 2022;12(24). Doi: 10.3390/ani12243546.

Meng X, Xie Y, Gu X, Zheng Y, Liu Y, Li Y, et al. Sequencing and analysis of the complete mitochondrial genome of dog roundworm Toxocara canis (Nematoda: Toxocaridae) from USA. Mitochondrial DNA B Resour. 2019;4(2):2999-3001. Doi: 10.1080/23802359.2019.1666042.

Wu TK, Fu Q, Liotta JL, Bowman DD. Proteomic analysis of extracellular vesicles and extracellular vesicle-depleted excretory-secretory products of Toxocara canis and Toxocara cati larval cultures. Vet Parasitol. 2024;332:110331. Doi: 10.1016/j.vetpar.2024.110331.

Kim HC, Hong EJ, Ryu SY, Park J, Cho JG, Yu DH, et al. Morphological and Molecular Characterization of Toxocara apodemi (Nematoda: Ascarididae) from Striped Field Mice, Apodemus agrarius, in Korea. Korean J Parasitol. 2020;58(4):403-11. Doi: 10.3347/kjp.2020.58.4.403.

Airs PM, Brown C, Gardiner E, Maciag L, Adams JP, Morgan ER. WormWatch: Park soil surveillance reveals extensive Toxocara contamination across the UK and Ireland. Vet Rec. 2023;192(1):e2341. Doi: 10.1002/vetr.2341.

Vanhee M, Dalemans AC, Viaene J, Depuydt L, Claerebout E. Toxocara in sandpits of public playgrounds and kindergartens in Flanders (Belgium). Vet Parasitol Reg Stud Reports. 2015;1-2:51-4. Doi: 10.1016/j.vprsr.2016.03.002.

Corda A, Tamponi C, Meloni R, Varcasia A, Parpaglia MLP, Gomez-Ochoa P, et al. Ultrasonography for early diagnosis of Toxocara canis infection in puppies. Parasitol Res. 2019;118(3):873-80. Doi: 10.1007/s00436-019-06239-4.

Schwartz R, Bidaisee S, Fields PJ, Macpherson MLA, Macpherson CNL. The epidemiology and control of Toxocara canis in puppies. Parasite Epidemiol Control. 2022;16:e00232. Doi: 10.1016/j.parepi.2021.e00232.

von Dohlen AR, Houk-Miles AE, Zajac AM, Lindsay DS. Flotation of Toxocara canis Eggs in Commercial Bleach and Effects of Bleach Treatment Times on Larval Development in These Eggs. J Parasitol. 2017;103(2):183-6. Doi: 10.1645/16-123.

Bonilla-Aldana JL, Espinosa-Nuñez AC, Bonilla-Aldana DK, Rodriguez-Morales AJ. Toxocara cati Infection in Cats (Felis catus): A Systematic Review and Meta-Analysis. Animals (Basel). 2024;14(7). Doi: 10.3390/ani14071022.

Hajipour N. A survey on the prevalence of Toxocara cati, Toxocara canis and Toxascaris leonina eggs in stray dogs and cats' faeces in Northwest of Iran: a potential risk for human health. Trop Biomed. 2019;36(1):143-51.

Marey N, El-Seify M, Abou Asa S, Satour N, Elhawary N, Sultan K. Toxocara cati larval migration in rats: experimental histopathological study. Ann Parasitol. 2021;67(2):265-73. Doi: 10.17420/ap6702.338.

Arslan F, Baysal NB, Aslan A, Simsek BC, Vahaboglu H. Toxocara related peritonitis: A case report and review of literature. Parasitol Int. 2019;73:101950. Doi: 10.1016/j.parint.2019.101950.

Michelutti A, Sgubin S, Falcaro C, Cagnin V, Zoroaster A, Danesi P. Detection of Toxocara cati Larvae from Ostrich and Wild Boar Meat Intended for Human Consumption. Pathogens. 2021;10(10). Doi: 10.3390/pathogens10101290.

Mohebi M, Aghamolaei S, Sohrabi MR, Khazan H, Rostami A. Serological diagnosis of Toxocara canis in mothers and their neonate referred to selected teaching hospitals, Tehran, Iran, 2020. J Parasit Dis. 2024;48(4):944-9. Doi: 10.1007/s12639-024-01725-8.

Holland CV. Knowledge gaps in the epidemiology of Toxocara: the enigma remains. Parasitology. 2017;144(1):81-94. Doi: 10.1017/s0031182015001407.

Lötsch F, Vingerling R, Spijker R, Grobusch MP. Toxocariasis in humans in Africa - A systematic review. Travel Med Infect Dis. 2017;20:15-25. Doi: 10.1016/j.tmaid.2017.10.009.

Rostami A, Ma G, Wang T, Koehler AV, Hofmann A, Chang BCH, et al. Human toxocariasis - A look at a neglected disease through an epidemiological 'prism'. Infect Genet Evol. 2019;74:104002. Doi: 10.1016/j.meegid.2019.104002.

Healy SR, Morgan ER, Prada JM, Betson M. First report demonstrating the presence of Toxocara spp. eggs on vegetables grown in community gardens in Europe. Food Waterborne Parasitol. 2022;27:e00158. Doi: 10.1016/j.fawpar.2022.e00158.

Martin KA, Jesudoss Chelladurai JRJ, Bsrat A, Pulaski C, Lee ACY, Starkey LA, et al. Haplotypic analysis of cox1 from Toxocara canis demonstrates five distinct clades that are not geographically defined. PLoS Negl Trop Dis. 2023;17(10):e0011665. Doi: 10.1371/journal.pntd.0011665.

Nijsse R, Mughini-Gras L, Wagenaar JA, Ploeger HW. Recurrent patent infections with Toxocara canis in household dogs older than six months: a prospective study. Parasit Vectors. 2016;9(1):531. Doi: 10.1186/s13071-016-1816-7.

Healy SR, Morgan ER, Prada JM, Betson M. Brain food: rethinking food-borne toxocariasis. Parasitology. 2022;149(1):1-9. Doi: 10.1017/s0031182021001591.

Patterson J. Toxocarosis in humans: how much of a problem is it in the UK? Drug Ther Bull. 2023;61(1):7-11. Doi: 10.1136/dtb.2022.000052.

Delgado O, Rivas MA, Coraspe V, Silva S, Dos Santos ML, Centeno Y, et al. Caracterización de casos atendidos de toxocariasis visceral y ocular en el Instituto de Medicina Tropical, Caracas, Venezuela, 2011-2016. Tribuna del Investigador. 2018;19(1):77-84.

Rodríguez-Caballero A, Martínez-Gordillo MN, Caballero-Salazar S, Rufino-González Y, Ponce-Macotela M. Toxocara canis: Analysis of the kinetics of antigen release and antibody production in an in vivo model for the detection of past or present infection. Vet Parasitol. 2017;243:183-7. Doi: 10.1016/j.vetpar.2017.06.027.

Strube C, Waindok P, Raulf MK, Springer A. Toxocara-induced neural larva migrans (neurotoxocarosis) in rodent model hosts. Adv Parasitol. 2020;109:189-218. Doi: 10.1016/bs.apar.2020.01.006.

Zibaei M. Helminth Infections and Cardiovascular Diseases: Toxocara Species is Contributing to the Disease. Curr Cardiol Rev. 2017;13(1):56-62. Doi: 10.2174/1573403x12666160803100436.

Kim HG, Yang JW, Hong SC, Lee YJ, Ju YT, Jeong CY, et al. Toxocara canis Mimicking a Metastatic Omental Mass from Sigmoid Colon Cancer: A Case Report. Ann Coloproctol. 2018;34(3):160-3. Doi: 10.3393/ac.2017.12.20.

Kong L, Peng HJ. Current epidemic situation of human toxocariasis in China. Adv Parasitol. 2020;109:433-48. Doi: 10.1016/bs.apar.2020.01.016.

Liotta JL, Helfer A, Huang L, Wu T, Bowman DD, Castillo C, et al. Synergistic effects of using sodium hypochlorite (bleach) and desiccation in surface inactivation for Toxocara spp. Exp Parasitol. 2024;261:108753. Doi: 10.1016/j.exppara.2024.108753.

Chieffi PP, Müller EE. [Prevalence of parasitic diseases by Toxocara canis in dogs, and the finding of eggs of Toxocara species in the soil of public places in the urban area of Londrina, State of Parana, Brazil]. Rev Saude Publica. 1976;10(4):367-72.

Martinez Baez M, Aleman P. [Visceral larva migrans. First case discovered in Mexico. I. Histopathological study]. Rev Inst Salubr Enferm Trop. 1960;20:65-72.

Taranto NJ, Passamonte L, Marinconz R, de Marzi MC, Cajal SP, Malchiodi EL. [Zoonotic parasitosis transmitted by dogs in the Chaco Salteño, Argentina]. Medicina (B Aires). 2000;60(2):217-20.

Hersković P, Astorga B. [Human toxocariasis in Chile]. Rev Med Chil. 1985 [Cited 2024 Jan 13];113(1):18-21. Available from: https://pubmed.ncbi.nlm.nih.gov/4081379/

Lynch NR, Eddy K, Hodgen AN, Lopez RI, Turner KJ. Seroprevalence of Toxocara canis infection in tropical Venezuela. Trans R Soc Trop Med Hyg. 1988;82(2):275-81. Doi: 10.1016/0035-9203(88)90446-4.

Sariego I, Kanobana K, Rojas L, Speybroeck N, Polman K, Núñez FA. Toxocariasis in Cuba: a literature review. PLoS Negl Trop Dis. 2012;6(2):e1382. Doi: 10.1371/journal.pntd.0001382.

Delgado O, Botto C, Mattei R, Escalante A. Effect of albendazole in experimental toxocariasis of mice. Ann Trop Med Parasitol. 1989;83(6):621-4. Doi: 10.1080/00034983.1989.11812396.

Herrera L, López L, Ponte-Sucre A. An approach to women scientists and parasitologists in Latin America and the Caribbean from a gender perspective. Boletin de la Academia de Ciencias Fisicas, Matematicas y Naturales. 2024;84(2):19-32.

Tecnología; MdPPpCy. Mujeres de las Ciencias en Venezuela. Available at: https://lawebdelasalud.com/wp-content/uploads/2025/02/Libro-mujeres-de-la-Ciencia-digital_-1.pdf2024.

Uzcátegui Z, Essayag SM. Recuento histórico del Departamento de Microbiología, Parasitología y Medicina Tropical. Tribuna del Investigador. 2018;19(1):33-46.

Delgado OM, Fernandez G, Silva S, Ramirez O, Romero J, Rodriguez-Morales AJ. Preliminary evidence of nitazoxanide activity on Toxocara canis in a mouse model. Int J Antimicrob Agents. 2008;31(2):182-4. Doi: 10.1016/j.ijantimicag.2007.10.008.

Delgado OM, Rosas-Bustamante J, Ortegoza J, Duarte E, Coraspe V, Rivas M, et al. Acute cases of toxocariasis classified by IGG antibodies avidity in Venezuela. J Egypt Soc Parasitol. 2011;41(3):611-4.

Salazar F, Rada L, Salazar M, Reyna M, Rodriguez-Morales A, Delgado O. Síndrome de activación macrofágica secundario a sindrome de larva migrans visceral por Toxocara canis. Archivos Venezolanos de Puericultura y Pediatría. 2009;72(Suppl 3):43-4.

Martínez-Pulgarín DF, Muñoz-Urbano M, Gomez-Suta LD, Delgado OM, Rodriguez-Morales AJ. Ocular toxocariasis: new diagnostic and therapeutic perspectives. Recent Pat Antiinfect Drug Discov. 2015;10(1):35-41. Doi: 10.2174/1574891x10666150410125057.

Rodríguez-Morales AJ, Echeverri-Cataño LF, Delgado O. [Need for a consensus in the diagnosis of human toxocariasis: implications for the Latin American public health]. Rev Peru Med Exp Salud Publica. 2011;28(1):161-2. Doi: 10.1590/s1726-46342011000100029.

Prestes-Carneiro LE, Santarém V, Zago SC, Miguel NA, Zambelli Sde F, Villas R, et al. Sero-epidemiology of toxocariasis in a rural settlement in São Paulo state, Brazil. Ann Trop Med Parasitol. 2008;102(4):347-56. Doi: 10.1179/136485908x278801.

Fialho PM, Corrêa CR. A Systematic Review of Toxocariasis: A Neglected But High-Prevalence Disease in Brazil. Am J Trop Med Hyg. 2016;94(6):1193-9. Doi: 10.4269/ajtmh.15-0733.

Silva L, Dias IHL, Fonseca Á LS, Enk MJ, Nogueira JFC, Guimarães R, et al. Epidemiological profile of human toxocariasis in patients examined at Evandro Chagas Institute (IEC/SVSA/MS) between 2014 and 2019. Comp Immunol Microbiol Infect Dis. 2024;105:102112. Doi: 10.1016/j.cimid.2023.102112.

Lim PK, Yamasaki H, Mak JW, Wong SF, Chong CW, Yap IK, et al. Field evaluation of a rapid diagnostic test to detect antibodies in human toxocariasis. Acta Trop. 2015;148:32-7. Doi: 10.1016/j.actatropica.2015.04.011.

Turrientes MC, Perez de Ayala A, Norman F, Navarro M, Perez-Molina JA, Rodriquez-Ferrer M, et al. Visceral larva migrans in immigrants from latin america. Emerg Infect Dis. 2011;17(7):1263-5. Doi: 10.3201/eid1707.101204.

Virginia P, Nagakura K, Ferreira O, Tateno S. Serologic evidence of toxocariasis in northeast Brazil. Jpn J Med Sci Biol. 1991;44(1):1-6. Doi: 10.7883/yoken1952.44.1.

Anaruma Filho F, Chieffi PP, Correa CR, Camargo ED, Silveira EP, Aranha JJ, et al. Human toxocariasis: a seroepidemiological survey in the municipality of Campinas (SP), Brazil. Rev Inst Med Trop Sao Paulo. 2002;44(6):303-7. Doi: 10.1590/s0036-46652002000600002.

Chieffi PP, Ueda M, Camargo ED, de Souza AM, Guedes ML, Gerbi LJ, et al. Visceral larva migrans: a seroepidemiological survey in five municipalities of São Paulo state, Brazil. Rev Inst Med Trop Sao Paulo. 1990;32(3):204-10. Doi: 10.1590/s0036-46651990000300010.

Alcântara N, Bavia E, Silvão RM, Carvalho E. Environmental contamination by Toxocara sp eggs in public areas of Salvador, Bahia State, Brazil. Rev Soc Bras Med Trop. 1989;22(4):187-90. Doi: 10.1590/s0037-86821989000400005.

Escobar-Melguizo JA, Little MD. [Clinical case with parasitological confirmation of migratory visceral larva caused by Toxocara canis in Colombia]. Antioquia Med. 1966;16(6):499-507.

de-la-Torre A, López-Castillo CA, Rueda JC, Mantilla RD, Gómez-Marín JE, Anaya JM. Clinical patterns of uveitis in two ophthalmology centres in Bogota, Colombia. Clin Exp Ophthalmol. 2009;37(5):458-66. Doi: 10.1111/j.1442-9071.2009.02082.x.

Waindok P, Kann S, Aristizabal A, Dib JC, Strube C. Toxocara Seroprevalence and Risk Factor Analysis in Four Communities of the Wiwa, an Indigenous Tribe in Colombia. Microorganisms. 2021;9(8). Doi: 10.3390/microorganisms9081768.

Martínez M, Montero J, Pineda A, Mijares V, Lares M, Catalano E, et al. Epidemiological, clinical and laboratory features of toxocariasis in school children from Aragua State, Venezuela. Trans R Soc Trop Med Hyg. 2018;112(6):255-63. Doi: 10.1093/trstmh/try051.

Devera R, Blanco Y, Hernández H, Simoes D. [Toxocara spp. and other helminths in squares and parks of Ciudad Bolívar, Bolivar State (Venezuela)]. Enferm Infecc Microbiol Clin. 2008;26(1):23-6. Doi: 10.1157/13114391.

Morocoima A, Herrera L, Ruiz E, Córdova M, Ferrer E. [Ocular manifestations of toxocariasis in schoolchildren from the state from the Anzoátegui state in Venezuela]. Rev Peru Med Exp Salud Publica. 2021;38(4):621-6. Doi: 10.17843/rpmesp.2021.384.9322.

Lescano SA, Chieffi PP, Peres BA, de Mello EO, Velarde CN, Salinas AA, et al. Soil contamination and human infection by Toxocara sp. in the urban area of Lima, Peru. Mem Inst Oswaldo Cruz. 1998;93(6):733-4. Doi: 10.1590/s0074-02761998000600005.

Espinoza YA, Huapaya PH, Roldán WH, Jiménez S, Arce Z, Lopez E. Clinical and serological evidence of Toxocara infection in school children from Morrope district, Lambayeque, Peru. Rev Inst Med Trop Sao Paulo. 2008;50(2):101-5. Doi: 10.1590/s0036-46652008000200007.

Espinosa-Gómez FC, Bautista E, Palacios-Cruz OE, Téllez-Ramírez A, Vázquez-Briones DB, Flores de Los Ángeles C, et al. Host traits, ownership behaviour and risk factors of SARS-CoV-2 infection in domestic pets in Mexico. Zoonoses Public Health. 2023;70(4):327-40. Doi: 10.1111/zph.13030.

Atero N, Córdova-Bührle F, Salgado-Caxito M, Benavides JA, Fernández M, Diethelm-Varela B, et al. An assessment of the owned canine and feline demographics in Chile: registration, sterilization, and unsupervised roaming indicators. Prev Vet Med. 2024;226:106185. Doi: 10.1016/j.prevetmed.2024.106185.

Fadaei T, Saki J, Arjmand R, Jelowdar A. Toxoplasma gondii and Toxocara spp. contamination in university area. Ann Parasitol. 2024;70(2):101-11. Doi: 10.17420/ap7002.527.

Santarém VA, Doline FR, Ferreira IB, Farinhas JH, Biondo LM, de Souza Filho RT, et al. One health approach to toxocariasis in Brazilian indigenous populations, their dogs, and soil contamination. Front Public Health. 2023;11:1220001. Doi: 10.3389/fpubh.2023.1220001.

Alvarado-Esquivel C. Seroepidemiology of toxocariasis in a rural Tepehuanos population from Durango, Mexico. J Helminthol. 2014;88(2):173-6. Doi: 10.1017/s0022149x12000880.

Diez Roux AV, Slesinski SC, Alazraqui M, Caiaffa WT, Frenz P, Jordán Fuchs R, et al. A Novel International Partnership for Actionable Evidence on Urban Health in Latin America: LAC-Urban Health and SALURBAL. Glob Chall. 2019;3(4):1800013. Doi: 10.1002/gch2.201800013.

Wilke ABB, Farina P, Ajelli M, Canale A, Dantas-Torres F, Otranto D, et al. Human migrations, anthropogenic changes, and insect-borne diseases in Latin America. Parasit Vectors. 2025;18(1):4. Doi: 10.1186/s13071-024-06598-7.

Won KY, Kruszon-Moran D, Schantz PM, Jones JL. National seroprevalence and risk factors for Zoonotic Toxocara spp. infection. Am J Trop Med Hyg. 2008;79(4):552-7.

Kroten A, Toczylowski K, Kiziewicz B, Oldak E, Sulik A. Environmental contamination with Toxocara eggs and seroprevalence of toxocariasis in children of northeastern Poland. Parasitol Res. 2016;115(1):205-9. Doi: 10.1007/s00436-015-4736-0.

Lassen B, Jokelainen P. Survey of the Presence of Toxocara spp. Eggs in Dog Feces in Tartu, Estonia. Vector Borne Zoonotic Dis. 2016;16(3):212-4. Doi: 10.1089/vbz.2015.1895.

Avila HG, Sandon L, Anes PE, Meli SA, Giboin GA, Pérez VM, et al. Environmental Toxocara spp. presence in crowded squares and public parks from San Juan Province, Argentina: A call for a "One Health" approach. Front Med (Lausanne). 2023;10:1102396. Doi: 10.3389/fmed.2023.1102396.

Delai RR, Freitas AR, Kmetiuk LB, Merigueti Y, Ferreira IB, Lescano SAZ, et al. One Health approach on human seroprevalence of anti-Toxocara antibodies, Toxocara spp. eggs in dogs and sand samples between seashore mainland and island areas of southern Brazil. One Health. 2021;13:100353. Doi: 10.1016/j.onehlt.2021.100353.

Hotez PJ, Wilkins PP. Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance? PLoS Negl Trop Dis. 2009;3(3):e400. Doi: 10.1371/journal.pntd.0000400.

Pavletic CF, Larrieu E, Guarnera EA, Casas N, Irabedra P, Ferreira C, et al. Cystic echinococcosis in South America: a call for action. Rev Panam Salud Publica. 2017;41:e42. Doi: 10.26633/rpsp.2017.42.

Crompton DW, Nesheim MC. Nutritional impact of intestinal helminthiasis during the human life cycle. Annu Rev Nutr. 2002;22:35-59. Doi: 10.1146/annurev.nutr.22.120501.134539.

Głuchowska K, Dzieciątkowski T, Sędzikowska A, Zawistowska-Deniziak A, Młocicki D. The New Status of Parasitic Diseases in the COVID-19 Pandemic-Risk Factors or Protective Agents? J Clin Med. 2021;10(11). Doi: 10.3390/jcm10112533.

Taylor MR, Keane CT, O'Connor P, Girdwood RW, Smith H. Clinical features of covert toxocariasis. Scand J Infect Dis. 1987;19(6):693-6. Doi: 10.3109/00365548709117206.

Finsterer J, Kallab V, Auer H. Neurotoxocariasis associated with lower motor neuron disease. Report of one case. Rev Med Chil. 2010;138(4):483-6.

Deshayes S, Bonhomme J, de La Blanchardière A. Neurotoxocariasis: a systematic literature review. Infection. 2016;44(5):565-74. Doi: 10.1007/s15010-016-0889-8.

Magnaval JF, Fillaux J, Berry A. A Retrospective Study of the Efficacy of Albendazole and Diethylcarbamazine for the Treatment of Human Toxocariasis. Pathogens. 2022;11(7). Doi: 10.3390/pathogens11070813.

Magnaval JF, Bouhsira E, Fillaux J. Therapy and Prevention for Human Toxocariasis. Microorganisms. 2022;10(2). Doi: 10.3390/microorganisms10020241.

Bolívar-Mejía A, Rodríguez-Morales AJ, Paniz-Mondolfi AE, Delgado O. [Cardiovascular manifestations of human toxocariasis]. Arch Cardiol Mex. 2013;83(2):120-9. Doi: 10.1016/j.acmx.2012.07.002.

Ardekani A, Roshanshad A, Hosseini SA, Magnaval JF, Abdollahi A, Rostami A. Toxocariasis-associated urinary system diseases: a systematic review of reported cases. Trans R Soc Trop Med Hyg. 2022;116(7):668-72. Doi: 10.1093/trstmh/trab177.

Krásný J, Šach J. Forms of Ocular Larval Toxocariasis in Childhood. A Review. Cesk Slov Oftalmol. 2023;79(2):59-67. Doi: 10.31348/2022/28.

Campbell JP, Wilkinson CP. Imaging in the diagnosis and management of ocular toxocariasis. Int Ophthalmol Clin. 2012;52(4):145-53. Doi: 10.1097/IIO.0b013e318265d58b.

El Meski N, El Ayoubi LW, Hassani S, Bidikian N, Zakhour J, Bou Khalil J, et al. Clinical Spectrum of Toxocariasis: A Retrospective Study From a Tertiary Care Center in Lebanon. Future Microbiol. 2025:1-9. Doi: 10.1080/17460913.2025.2477919.

Jones JL, Kruszon-Moran D, Won K, Wilson M, Schantz PM. Toxoplasma gondii and Toxocara spp. co-infection. Am J Trop Med Hyg. 2008;78(1):35-9.

Pereira E, Ferreira IB, Victorino RB, Lescano SAZ, Giuffrida R, Kmetiuk LB, et al. Serosurvey of Toxoplasma gondii and Toxocara spp. co-infection in pregnant women in low-income areas of Brazil. Front Public Health. 2024;12:1340434. Doi: 10.3389/fpubh.2024.1340434.

Kim SW, Jang BK. Toxocara canis and Fasciola hepatica Co-Infection Leading to Hepatic Abscess: A Case Report. J Korean Med Sci. 2023;38(39):e323. Doi: 10.3346/jkms.2023.38.e323.

Mitic I, Gnjatovic M, Vasilev S, Ristovic N, Miladinovic-Tasic N, Sofronic-Milosavljevic L. Two trichinellosis outbreaks in Serbia - challenging diagnosis due to a potential co-infection with Toxocara spp. J Helminthol. 2022;96:e83. Doi: 10.1017/s0022149x22000712.

Guneratne R, Mendis D, Bandara T, Fernando SD. Toxoplasma, toxocara and tuberculosis co-infection in a four year old child. BMC Pediatr. 2011;11:44. Doi: 10.1186/1471-2431-11-44.

Zwickl L, Joekel DE, Fischer NM, Rostaher A, Thamsborg K, Deplazes P, et al. Total and Toxocara canis larval excretory/secretory antigen- and allergen-specific IgE in atopic and non-atopic dogs. Vet Dermatol. 2018;29(3):222-e80. Doi: 10.1111/vde.12527.

Aghaei S, Riahi SM, Rostami A, Mohammadzadeh I, Javanian M, Tohidi E, et al. Toxocara spp. infection and risk of childhood asthma: A systematic review and meta-analysis. Acta Tropica. 2018;182:298-304. Doi: https://doi.org/10.1016/j.actatropica.2018.03.022.

Li L, Gao W, Yang X, Wu D, Bi H, Zhang S, et al. Asthma and toxocariasis. Annals of Allergy, Asthma & Immunology. 2014;113(2):187-92. Doi: https://doi.org/10.1016/j.anai.2014.05.016.

Quattrocchi G, Nicoletti A, Marin B, Bruno E, Druet-Cabanac M, Preux PM. Toxocariasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6(8):e1775. Doi: 10.1371/journal.pntd.0001775.

Luna J, Cicero CE, Rateau G, Quattrocchi G, Marin B, Bruno E, et al. Updated evidence of the association between toxocariasis and epilepsy: Systematic review and meta-analysis. PLoS Negl Trop Dis. 2018;12(7):e0006665. Doi: 10.1371/journal.pntd.0006665.

Çelik T, Kaplan Y, Ataş E, Öztuna D, Berilgen S. Toxocara seroprevalence in patients with idiopathic Parkinson's disease: chance association or coincidence? Biomed Res Int. 2013;2013:685196. Doi: 10.1155/2013/685196.

Khatir AA, Abbasi A, Sarandili S, Sepidarkish M, Fazlollahpour-Naghibi A, Arjmandi D, et al. The association between Parkinson disease and Toxocara infection/exposure: A case-control study. J Helminthol. 2025;99:e40. Doi: 10.1017/s0022149x25000161.

Delgado OM, Ramírez E, Rivas M, Rosas J, Rodríguez-Morales AJ. Evaluación del desempeño diagnóstico de la ELISA RIDASCREEN® en la toxocariasis humana. Infectio. 2014;18(S1):79.

Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, et al. Human toxocariasis. Lancet Infect Dis. 2018;18(1):e14-e24. Doi: 10.1016/s1473-3099(17)30331-6.

Fonseca GRE, Grossi de Oliveira AL, Brito RMM, Corral MA, Ward RJ, de Lima PA, et al. Immunogenic mapping of potential epitopes from Tc-CTL-1 for the diagnosis of murine toxocariasis. Mem Inst Oswaldo Cruz. 2025;120:e240111. Doi: 10.1590/0074-02760240111.

Espinoza Y, Huapaya P, Suárez R, Chávez V, Sevilla C, Dávila E, et al. Estandarización de la técnica de ELISA para el diagnóstico de Toxocariasis humana. Anales de la Facultad de Medicina. 2003;64:7-12.

Mohamad S, Azmi NC, Noordin R. Development and evaluation of a sensitive and specific assay for diagnosis of human toxocariasis by use of three recombinant antigens (TES-26, TES-30USM, and TES-120). J Clin Microbiol. 2009;47(6):1712-7. Doi: 10.1128/jcm.00001-09.

Brunello F, Falagiani P, Genchi C. Enzyme immunoassay (ELISA) for the detection of specific IgG antibodies to Toxocara canis ES antigens. Boll Ist Sieroter Milan. 1986;65(1):54-60.

Magnaval JF, Malard L, Morassin B, Fabre R. Immunodiagnosis of ocular toxocariasis using Western-blot for the detection of specific anti-Toxocara IgG and CAP for the measurement of specific anti-Toxocara IgE. J Helminthol. 2002;76(4):335-9. Doi: 10.1079/joh2002143.

Aguiar-Santos AM, Andrade LD, Medeiros Z, Chieffi PP, Lescano SZ, Perez EP. Human toxocariasis: frequency of anti-Toxocara antibodies in children and adolescents from an outpatient clinic for lymphatic filariasis in Recife, Northeast Brazil. Rev Inst Med Trop Sao Paulo. 2004;46(2):81-5. Doi: 10.1590/s0036-46652004000200005.

Roldán WH, Elefant GR, Ferreira AW. Deglycosylation of Toxocara excretory-secretory antigens improves the specificity of the serodiagnosis for human toxocariasis. Parasite Immunol. 2015;37(11):557-67. Doi: 10.1111/pim.12248.

Speiser F, Gottstein B. A collaborative study on larval excretory/secretory antigens of Toxocara canis for the immunodiagnosis of human toxocariasis with ELISA. Acta Trop. 1984;41(4):361-72.

Pouryousef A, Sarkari B, Mootabi Alavi A, Omidian M, Mikaeili F. Deglycosylation of Excretory-Secretory Antigens of the Second-Stage Larvae of Toxocara cati Improves Its Efficacy in the Diagnosis of Human Toxocariasis. J Trop Med. 2023;2023:3024063. Doi: 10.1155/2023/3024063.

Kaneva E, Rainova I, Harizanov R, Kaftandjiev I. Study of IgG avidity and the level of specific IgA antibodies and their significance in the diagnosis of human toxocarosis. Exp Parasitol. 2022;236-237:108236. Doi: 10.1016/j.exppara.2022.108236.

Dangoudoubiyam S, Vemulapalli R, Ndao M, Kazacos KR. Recombinant antigen-based enzyme-linked immunosorbent assay for diagnosis of Baylisascaris procyonis larva migrans. Clin Vaccine Immunol. 2011;18(10):1650-5. Doi: 10.1128/cvi.00083-11.

Kavitha KT, Sreekumar C, Latha BR, Gowri AM. Analysis of Seroreactivity and Seropositivity in Balb/c Mice Experimentally Infected with Toxocara canis Using Two Recombinant (rTc-CTL-1 and rTES-120) Antigens. Acta Parasitol. 2025;70(1):46. Doi: 10.1007/s11686-024-00940-w.

Noordin R, Yunus MH, Tan Farrizam SN, Arifin N. Serodiagnostic methods for diagnosing larval toxocariasis. Adv Parasitol. 2020;109:131-52. Doi: 10.1016/bs.apar.2020.01.003.

Baharudeen Z, Noordin R, Soon LT, Balachandra D, Anuar NS, Mustafa FH, et al. Isolation and Production of Human Monoclonal Antibody Proteins against a Toxocara canis Excretory-Secretory Recombinant Antigen. Pathogens. 2022;11(11). Doi: 10.3390/pathogens11111232.

del Aguila C, Cuellar C, Guillén JL. Excretory/secretory antigen of Toxocara canis: recognition profiles of polyclonal and larvicidal monoclonal antibodies. Parasite Immunol. 1988;10(2):237-41. Doi: 10.1111/j.1365-3024.1988.tb00217.x.

Bellanger AP, Humbert P, Gavignet B, Deschaseaux AD, Barisien C, Roussel S, et al. Comparative assessment of enzyme-linked immunosorbent assay and Western blot for the diagnosis of toxocariasis in patients with skin disorders. Br J Dermatol. 2010;162(1):80-2. Doi: 10.1111/j.1365-2133.2009.09411.x.

el-Massry AA. Characterization of antigenic property of Toxocara canis and Toxascaris leonina adults and larvae through immunodiagnostic electrophoresis (SDS-PAGE) and western blot technique. J Egypt Soc Parasitol. 1999;29(2):335-45.

Raulf MK, Jordan D, Auer H, Warnecke JM, Lepenies B, Strube C. A new ELISA and western blot technique based on recombinant TES antigen and/or larval antigen for the detection of toxocariasis in humans. Parasitology. 2021;148(3):333-40. Doi: 10.1017/S0031182020002085.

Morales OL, Lopez MC, Nicholls RS, Agudelo C. Identification of toxocara canis antigens by Western blot in experimentally infected rabbits. Rev Inst Med Trop Sao Paulo. 2002;44(4):213-6. Doi: 10.1590/s0036-46652002000400006.

da Silva Raposo R, Santarem VA, Merigueti YF, Rubinsky-Elefant G, de Lima Cerazo LM, Pereira L, et al. Kinetic and avidity of IgY anti-Toxocara antibodies in experimentally infected chickens. Exp Parasitol. 2016;171:33-41. Doi: 10.1016/j.exppara.2016.09.009.

Dziemian E, Zarnowska H, Kolodziej-Sobocinska M, Machnicka B. Determination of the relative avidity of the specific IgG antibodies in human toxocariasis. Parasite Immunol. 2008;30(3):187-90. Doi: 10.1111/j.1365-3024.2007.01010.x.

Rudzinska M, Kowalewska B, Sikorska K. Clinical usefulness of Western blotting and ELISA avidity for the diagnosis of human toxocariasis. Parasite Immunol. 2017;39(1). Doi: 10.1111/pim.12400.

Fenoy S, Rodero M, Pons E, Aguila C, Cuellar C. Follow-up of antibody avidity in BALB/c mice infected with Toxocara canis. Parasitology. 2008;135(6):725-33. Doi: 10.1017/S0031182008004368.

Menu E, Kopec L, Luciani L, Legrand S, L'Ollivier C. Measurement of the IgG Avidity Index in the Diagnosis of Clinical Toxocariasis Patients. Pathogens. 2021;10(9). Doi: 10.3390/pathogens10091086.

Bin LL, Santarem VA, Laposy CB, Rubinsky-Elefant G, Roldan WH, Giuffrida R. Kinetics and avidity of anti-Toxocara antibodies (IgG) in rabbits experimentally infected with Toxocara canis. Rev Bras Parasitol Vet. 2016;25(1):99-104. Doi: 10.1590/S1984-29612015067.

Schoenardie ER, Scaini CJ, Avila LF, Sperotto RL, Borsuk S, Felicetti CD, et al. Determination of IgG avidity in BALB/c mice experimentally infected with Toxocara canis. Rev Bras Parasitol Vet. 2014;23(3):403-6. Doi: 10.1590/s1984-29612014060.

Rychlicki W. [Use of specific immunoglobulin G antibody avidity in the differential diagnosis of active and chronic Toxocara canis infections]. Wiad Parazytol [Internet]. 2004 [Cited 2024 Jan 14];50(2):229-36. Available from: https://pubmed.ncbi.nlm.nih.gov/16859028/

Al-Awadhi M, Jamal W. Seroprevalence of toxocariasis among allergic patients in Kuwait and its association with eosinophilia. Parasite Epidemiol Control. 2022;18:e00260. Doi: 10.1016/j.parepi.2022.e00260.

Leal-Silva T, Lopes CA, Vieira-Santos F, Oliveira FMS, Kraemer L, Padrao LLS, et al. Tissue eosinophilia correlates with mice susceptibility, granuloma formation, and damage during Toxocara canis infection. Parasitology. 2022:1-38. Doi: 10.1017/S0031182022000075.

Reis J, Carmo F, Miranda J, Seixas AP, Mota M. Eosinophilia and IgE Elevation: An Uncommon Toxocara Infection. Cureus. 2025;17(1):e77965. Doi: 10.7759/cureus.77965.

Dattoli VC, Freire SM, Mendonca LR, Santos PC, Meyer R, Alcantara-Neves NM. Toxocara canis infection is associated with eosinophilia and total IgE in blood donors from a large Brazilian centre. Trop Med Int Health. 2011;16(4):514-7. Doi: 10.1111/j.1365-3156.2010.02719.x.

Hodzic A, Mateos-Hernandez L, Frealle E, Roman-Carrasco P, Alberdi P, Pichavant M, et al. Infection with Toxocara canis Inhibits the Production of IgE Antibodies to alpha-Gal in Humans: Towards a Conceptual Framework of the Hygiene Hypothesis? Vaccines (Basel). 2020;8(2). Doi: 10.3390/vaccines8020167.

Newman AR, Leung B, Richards A, Campbell TG, Wellwood J, Imrie FR. Two cases of differentiation syndrome with ocular manifestations in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and arsenic trioxide. Am J Ophthalmol Case Rep. 2018;9:106-11. Doi: 10.1016/j.ajoc.2018.01.026.

Juárez XS, Delgado M, Matteucci ED, Schiavino S, Pasinovich ME, García-Franco L, et al. [Toxocariasis in children: analysis of 85 cases in a paediatric hospital in Argentina]. Rev Chilena Infectol. 2021;38(6):761-7. Doi: 10.4067/s0716-10182021000600761.

Quintero Cusguen P, Gutiérrez Álvarez ÁM. Meningoencefalitis por neurotoxocarosis. Acta Neurológica Colombiana. 2013;29:109-11.

Fonseca GRe, Corral MA, Paula FMd, Meisel DMCL, Gryschek RCB, Lescano SAZ. Toxocara canis 30-35 kDa excretory-secretory antigen is an important marker in mice challenged by inocula containing different parasite load levels. Revista do Instituto de Medicina Tropical de São Paulo. 2022;64. doi: 10.1590/S1678-9946202264009.

Olave AM, Mesa JA, Botero JH, Patiño EB, García GM, Alzate JF. Producción y evaluación del antígeno recombinante TES-30 de Toxocara canis para el inmunodiagnóstico de toxocariasis. Biomédica. 2016;36:39-51. doi: 10.7705/biomedica.v36i1.2617

Lescano SZ, Chieffi PP, Amato Neto V, Ikai DK, Ribeiro MCSA. Anti-helmínticos na toxocaríase experimental: efeito na recuperação de larvas de Toxocara canis e na resposta humoral. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2005;41. doi: 10.1590/S1676-24442005000100006

Yunus MH, Tan Farrizam SN, Abdul Karim IZ, Noordin R. A Lateral Flow Rapid Test for Human Toxocariasis Developed Using Three Toxocara canis Recombinant Antigens. Am J Trop Med Hyg. 2018;98(1):32-8. Doi: 10.4269/ajtmh.17-0632.

Nakano S, Sugita S, Tomaru Y, Hono A, Nakamuro T, Kubota T, et al. Establishment of Multiplex Solid-Phase Strip PCR Test for Detection of 24 Ocular Infectious Disease Pathogens. Invest Ophthalmol Vis Sci. 2017;58(3):1553-9. Doi: 10.1167/iovs.16-20556.

Rodriguez-Morales AJ, Martinez-Pulgarin DF, Muñoz-Urbano M, Gómez-Suta D, Sánchez-Duque JA, Machado-Alba JE. Bibliometric Assessment of the Global Scientific Production of Nitazoxanide. Cureus. 2017;9(5):e1204. Doi: 10.7759/cureus.1204.

Yuan Y, Zhao Q, Suo X, Liu X, Hao Z. Anthelmintic efficacy of nitazoxanide in dogs naturally infected with Toxocara canis. Parasitol Res. 2024;123(3):162. Doi: 10.1007/s00436-024-08168-3.

Monteiro MB, Fragoso R, Foletto S, Lemos EM, Pereira FE. Intestinal helminthes and/or Toxocara infection are unrelated to anti-HBs titers in seven-year-old children vaccinated at birth with recombinant hepatitis B vaccine. Rev Soc Bras Med Trop. 2007;40(2):147-51. Doi: 10.1590/s0037-86822007000200001.

Totomoch-Serra A, Brito-Carreón CA, Manterola C. [Proteomics as a tool in vaccine development against Toxocariasis]. Rev Chilena Infectol. 2021;38(5):727-8. Doi: 10.4067/s0716-10182021000500727.

Jaramillo-Hernández DA, Salazar Garcés LF, Pacheco LGC, Pinheiro CS, Alcantara-Neves NM. Protective response mediated by immunization with recombinant proteins in a murine model of toxocariasis and canine infection by Toxocara canis. Vaccine. 2022;40(6):912-23. Doi: 10.1016/j.vaccine.2021.12.052.

Hafez EN, Awadallah FM, Ibrahim SA, Amin MM, El-Nawasera NZ. Assessment of vaccination with gamma radiationattenuated infective Toxocara canis eggs on murine toxocariasis. Trop Biomed [Internet]. 2020 [Cited 2024 Jan 18];37(1):89-102. Available from: https://pubmed.ncbi.nlm.nih.gov/33612721/

Salazar Garcés LF, Santiago LF, Santos SPO, Jaramillo Hernández DA, da Silva MB, Alves VDS, et al. Immunogenicity and protection induced by recombinant Toxocara canis proteins in a murine model of toxocariasis. Vaccine. 2020;38(30):4762-72. Doi: 10.1016/j.vaccine.2020.04.072.

Hafez EN, Hafez MN, Amin MM. Effect of vaccination with irradiated Toxocara canis larvae or thyme oil treatment on testicular histochemical and immunohistochemical changes of rats. Trop Biomed [Internet]. 2019 [Cited 2024 Jan 12];36(2):430-42. Available from: https://pubmed.ncbi.nlm.nih.gov/33597404/

Mationg ML, Clements ACA, Williams GM, Kelly M, Stewart DE, Gordon CA, et al. A study protocol for a multi-country cluster randomized controlled trial of the impact of a multi-component One Health strategy to eliminate Opisthorchis viverrini and soil transmitted helminths in the Lower Mekong Basin. Trials. 2024;25(1):801. Doi: 10.1186/s13063-024-08616-6.

Cuervo PF, Bargues MD, Artigas P, Buchon P, Angles R, Mas-Coma S. Heterogeneous zonal impacts of climate change on a wide hyperendemic area of human and animal fascioliasis assessed within a One Health action for prevention and control. PLoS Negl Trop Dis. 2025;19(1):e0012820. Doi: 10.1371/journal.pntd.0012820.

Ndossi BA, Mjingo EE, Park H, Lee D, Bia MM, Yang H, et al. Zoonotic Parasites and Their Association With Human Activities in Northern Tanzania: An Integrated Ecosystem Approach for One Health. J Parasitol Res. 2024;2024:8872837. Doi: 10.1155/2024/8872837.

Tarr A. Toxocarosis: a One Health issue. Drug Ther Bull. 2023;61(1):3. Doi: 10.1136/dtb.2022.000072.

Avila HG, Sandon L, Anes PE, Meli SA, Giboin GA, Perez VM, et al. Environmental Toxocara spp. presence in crowded squares and public parks from San Juan Province, Argentina: A call for a "One Health" approach. Front Med (Lausanne). 2023;10:1102396. Doi: 10.3389/fmed.2023.1102396.

Santarem VA, Doline FR, Ferreira IB, Farinhas JH, Biondo LM, de Souza Filho RT, et al. One health approach to toxocariasis in Brazilian indigenous populations, their dogs, and soil contamination. Front Public Health. 2023;11:1220001. Doi: 10.3389/fpubh.2023.1220001.

Delai RR, Freitas AR, Kmetiuk LB, Merigueti Y, Ferreira IB, Lescano SAZ, et al. One Health approach on human seroprevalence of anti-Toxocara antibodies, Toxocara spp. eggs in dogs and sand samples between seashore mainland and island areas of southern Brazil. One Health. 2021;13:100353. Doi: 10.1016/j.onehlt.2021.100353.

Santarem VA, Panazzolo GK, Kmetiuk LB, Domingues OJ, Ferreira IB, de Souza Filho RT, et al. One health approach to toxocariasis in quilombola communities of southern Brazil. Parasit Vectors. 2023;16(1):379. Doi: 10.1186/s13071-023-06010-w.

Santarem VA, Pinto GLB, de Souza Filho RT, Ferreira IB, Lescano SAZ, Gonzales WHR, et al. Risk factors for toxocariasis during incarceration: the One Health intervention approach. Sci Rep. 2023;13(1):19470. Doi: 10.1038/s41598-023-45484-7.

Hartnack S, Alobo G, Kankya C. Toxocariasis in Africa: A One Health perspective. Travel Med Infect Dis. 2017;20:3-4. Doi: 10.1016/j.tmaid.2017.11.001.

Pena A, Abarca K, Weitzel T, Gallegos J, Cerda J, Garcia P, et al. One Health in Practice: A Pilot Project for Integrated Care of Zoonotic Infections in Immunocompromised Children and Their Pets in Chile. Zoonoses Public Health. 2016;63(5):403-9. Doi: 10.1111/zph.12241.

Macpherson CNL. The epidemiology and public health importance of toxocariasis: A zoonosis of global importance. International Journal for Parasitology. 2013;43(12):999-1008. Doi: 10.1016/j.ijpara.2013.07.004.

Dantas-Torres F, Otranto D. Dogs, cats, parasites, and humans in Brazil: opening the black box. Parasites & Vectors. 2014;7(1):22. Doi: 10.1186/1756-3305-7-22.

Hotez PJ. Neglected parasitic infections and poverty in the United States. PLoS Negl Trop Dis. 2014;8(9):e3012. Doi: 10.1371/journal.pntd.0003012.

Rubinsky-Elefant G, Hirata CE, Yamamoto JH, Ferreira MU. Human toxocariasis: diagnosis, worldwide sero prevalences and clinical expression of the systemic and ocular forms. Ann Trop Med Parasitol. 2010;104(1):3-23. Doi: 10.1179/136485910x12607012373957.

Descargas

Publicado

17-05-2025

Número

Sección

Artículo de Revisión

Categorías

Cómo citar

1.
Toxocariasis: Una Enfermedad Tropical Desatendida y Descuidada en Latinoamérica. Rev. Cuerpo Med. HNAAA [Internet]. 2025 May 17 [cited 2026 Jul. 10];18(1):e2835. Available from: https://cmhnaaa.org.pe/index.php/rcmhnaaa/article/view/2835

Artículos más leídos del mismo autor/a

Artículos similares

1-10 de 295

También puede Iniciar una búsqueda de similitud avanzada para este artículo.